The aim of the joint study is to differentiate patients with favorable versus poor prognosis during diagnosis and primary treatment using definitive genetic markers. Nearly all prostate cancer situations in PSA-screened human population fall into a therefore called grey area of prostate cancers where outcome is incredibly difficult to predict at the time of diagnosis. The CRADA extends a long and already fruitful collaboration with USU’s Center for Prostrate Disease Research . This collaboration combines CPDR’s translational research assets and knowledge and Genomatix’ data evaluation knowledge in teasing out novel androgen receptor binding sites in the genome and examining prostate cancer metastasis using prostate cancers model systems and clinical specimens.The Hill: Sen. Chuck Grassley and Rep. Rosa DeLauro on Monday called for the diabetes drug Avandia to become pulled from the market in the wake of two new medical studies. Simultaneously, a report in the journal Cancer suggests that for men who’ve undergone medical procedures for prostate cancer, statin use appears to decrease the chance that the condition shall return. You can view the complete Kaiser Daily Health Policy Record, search the archives, or join email delivery of in-depth coverage of health policy developments, discussions and debates.